Objectives. We assessed the extent to which Centers for Disease Control and Prevention (CDC) recommendations have influenced routine HIV testing among Massachusetts community health center (CHC) personnel, and identified specific barriers and facilitators to routine testing.
In the United States, more than one million people are estimated to be living with human immunodeficiency virus (HIV); 21% are undiagnosed and/or remain unaware of their HIV infection. [1] [2] [3] Almost 40% are diagnosed late in the course of infection and receive an acquired immunodeficiency syndrome (AIDS) diagnosis within one year of their first positive HIV test result. 3 To address the large number of undiagnosed HIV cases and high proportion of individuals presenting late to care, the Centers for Disease Control and Prevention (CDC) published revised recommendations in September 2006 that sought to establish HIV testing as a routine component of medical care similar to other screening procedures. Specifically, the CDC guidelines recommend that providers in all health-care settings, including hospital emergency departments, primary care practices, and community clinics, offer voluntary HIV testing to all patients aged 13-64 years and all pregnant women as an opt-out procedure, meaning that patients are to be notified that an HIV test will be conducted unless the patient declines. 4 Separate written consent and prevention counseling as prerequisites for testing are no longer recommended.
Release of the revised recommendations has sparked a national debate, and responses among the medical community have been mixed, with a majority of U.S. health professional organizations endorsing all or parts of the CDC recommendations. [5] [6] [7] While potentially increasing rates of HIV testing by streamlining consent 8 and reducing associated stigma through normalization as a routine clinical procedure, 9, 10 the elimination of a separate consent process and mandatory prevention counseling remains incompatible with several state laws or regulations and has been met with some concern. 5, [11] [12] [13] [14] Physician barriers to HIV testing include insufficient time, burdensome consent process, lack of knowledge/training about HIV testing and the CDC revised recommendations, difficulty locating HIV testing consent forms, lack of patient acceptance, competing priorities, and inadequate reimbursement. 15, 16 A growing body of research has examined efforts to improve HIV testing rates in a variety of health-care settings, including a public, urban medical care system, 17 U.S. Department of Veterans Affairs health-care facilities, 18, 19 hospital emergency departments, 20 a sexually transmitted disease (STD) clinic, 21 and community health centers (CHCs). [22] [23] [24] However, while studies of CHCs have described programs to implement routine testing and largely reported patient-level data, little research to date has examined barriers to implementation among CHC personnel. CHCs represent an important source of primary care for people who are low-income, from racial/ethnic and sexual minority groups, immigrants, and those seeking mental health and substance abuse treatment services. 25 These populations are also disproportionately affected by HIV/AIDS, suggesting that CHCs can and do serve as an important resource for HIV/AIDS prevention and treatment. 26 In fact, from 1999 to 2004, CHCs conducted 7% of the total HIV tests supported by CDC yet identified 12% of the total HIV-positive results. 27 In Massachusetts, providers face unique barriers to implementing routine testing. Despite the issuance of a June 2009 clinical advisory by the state health department supporting routine HIV testing in primary and urgent care settings, state law requires specific written informed consent before testing a patient for HIV, which is inconsistent with CDC's recommendation to no longer require separate informed consent. [28] [29] [30] [31] Consequently, written informed consent may be perceived as a barrier for providers to offer routine testing to patients, as this process typically requires a detailed conversation and providers are often working under already limited time constraints. 8, 16 Understanding the facilitators and barriers to the implementation of routine HIV testing among CHCs in Massachusetts may have relevance to other U.S. states, where laws remain inconsistent with CDC HIV testing guidelines. 30, 31 We sought to gain a better understanding of HIV testing efforts among Massachusetts CHC personnel, including awareness of the CDC revised recommendations and any efforts to implement and support routine HIV testing in primary care settings. Analyses were stratified by respondent type (i.e., medical provider, administrator, and director) and funding mechanism, comparing health centers that did and did not receive support from the Ryan White HIV/AIDS Program, the federal program primarily responsible for HIVrelated health services. 32 Understanding the barriers and facilitators to implementing CDC's revised recommendations may prove useful for designing educational materials and structural or individual-level interventions that will aid in conducting testing procedures in a more effective and efficient way.
METHODS

Participants and procedures
There are 52 CHCs in Massachusetts; 42% receive funding support from at least one part of the Ryan White HIV/AIDS Program. 33, 34 Seeking statewide representation, health centers participating in the study were selected based on community rates of HIV/AIDS, then geographic location, and factors associated with health disparities, including racial/ethnic composition and poverty levels. From April to December 2008, 31 CHCs representing 60% of the state's total number of CHCs were enrolled in the study: 15 health centers that received Ryan White funding support were compared with 16 health centers that did not directly receive Ryan White funding, matched on location, community composition, and rates of HIV/AIDS. Twenty-three CHCs were located within the Greater Boston metropolitan area, four health centers were from the southeast and Cape Cod, and four were from the state's central and western districts.
Recruitment
Following the identification of potential health centers, the study team contacted a senior administrator from each CHC to explain the study and invite the organization to participate. A staff person at each agency was next identified to serve as a study liaison, subsequently explaining the study to the appropriate personnel, distributing study materials, and coordinating receipt of compensation. Only three health centers that were asked to participate declined and were replaced with comparable health centers.
Survey implementation
An anonymous survey was administered to a maximum five personnel from each CHC, including (1) a seniorlevel administrator of the agency (e.g., the executive director or another high-level administrator knowledgeable of the agency's HIV/AIDS services), (2) the medical director of the agency, and (3) three medical providers (e.g., medical doctors, nurse practitioners, and physician's assistants). Participants completed the survey either through a secure website or on paper, returning paper surveys to the study team via self-addressed stamped envelopes. Compensation for completion of each survey was $500, which was paid directly to the health center. Study participation was completely voluntary for both individual respondents and their respective health centers, and all study procedures received appropriate institutional review board approvals, including a waiver of informed consent for participants completing the anonymous survey.
Measures
Survey questions were adapted from a national survey of CHCs regarding HIV testing, prevention, care, and treatment practices, and a national survey to assess health department efforts to implement and support routine HIV testing programs. 35, 36 The anonymous survey asked questions regarding the provision of HIV services, including the gender, age, and race/ethnicity of HIV-infected patients; and perceptions, understanding, and experiences with HIV testing, including routine HIV testing. Administrators were also asked questions about relevant agency operations, such as funding for HIV services, their understanding of the CDC revised recommendations, and the regulatory and legal environment regarding routine HIV testing. Medical directors and other medical providers were instructed to respond from the perspective of their individual clinical practice; administrators were asked to respond from the perspective of their respective health centers. For this study, routine HIV testing was defined as "voluntary HIV testing performed for all patients in a setting unless the patient specifically declines HIV testing (i.e., 'opt-out' testing)." 36 To the question, "What are the most significant barriers to implementing routine HIV testing in your health center and related divisions, settings, or programs?", respondents were asked to indicate all that applied among a list of 27 possible barriers. Additional health center factors measured in the survey were the personnel, technologies, and settings used to conduct HIV testing, and the presence of written procedures, including those that require providers to offer HIV testing, provide risk assessments and pre/posttest counseling, and discuss sexual behaviors and substance use with patients. The survey also asked about intentions to address routine HIV testing in the future.
Data analysis
We used SAS ® version 9.1 37 to perform analyses and determined statistical significance at p0.05.
As medical directors and other medical providers were instructed to respond from their individual clinical practice, these responses were combined for descriptive statistics, which were conducted to compare responses between health center administrators and medical directors/providers and to compare responses between health centers that did and did not receive direct Ryan White funding support at the time of the study. We used Chi-square global tests of independence and Fisher's exact tests to examine independent associations between variables. Due to the non-symmetric distributions of the number of HIV-infected patients served in the past 12 months, the annual number of HIV tests performed, and annual funding for HIV testing, median and interquartile range (IQR) values were calculated to capture the general tendency of the data. We used the Wilcoxon rank-sum test, a nonparametric equivalent to the two-sample t-test, to test these distributions with respect to the median.
Bivariate and multivariable logistic regression models
Dependent variable. For the purpose of this analysis, the primary outcome was a dichotomous measure of whether or not respondents indicated that they, or in the case of administrators, their respective health centers, had implemented routine HIV testing. Specifically, medical directors and providers were asked, "Have you implemented routine HIV testing in your practice?"; administrators were asked, "Has your health center implemented routine HIV testing in any care setting?" Independent variables. Independent variables for this analysis included demographic profiles of each health center, including the number, gender, age, and racial/ ethnic composition of HIV-infected patients; the type of respondent (administrator, medical director, or medical provider); the 10 most frequently reported perceived barriers to conducting routine HIV testing; and other health center factors, such as personnel and technologies used for testing, and the presence of required written procedures.
We used bivariate logistic regression procedures to examine associations between our outcome of interest and each independent variable. To fit the most parsimonious multivariable model, we used the backward elimination process, in which we started with a model that contained all the statistically significant bivariate predictors and used SAS procedures to systematically remove the largest nonsignificant p-value terms until we identified a subset model that consisted of entirely statistically significant terms.
RESULTS
Health center characteristics and HIV testing
A total of 137 health center personnel completed surveys, including 31 senior administrators, 29 medical directors, and 77 medical providers. Table 1 (Table 1) .
While personnel from both types of health centers were similar in the proportion reporting the use of on-site conventional blood tests to conduct HIV testing, Ryan White-supported health center personnel reported higher frequencies in the use of on-site conventional oral testing (30% Ryan White providers vs. 12% non-Ryan White providers, p0.05) and on-site rapid testing (64% Ryan White providers vs. 14% non-Ryan White providers, p0.001) ( Table 1) . Ninety-seven percent of Ryan White-supported personnel and 100% of non-Ryan White-supported personnel indicated that patients were required to sign written consent for HIV tests provided by their health centers (data not shown).
Routine HIV testing.
Overall, 38% of survey respondents identified that routine testing had been implemented in their health centers. Among these respondents, routine testing had been primarily implemented in the divisions of prenatal/obstetrical care (66%), family medicine (66%), dedicated HIV testing program (52%), family planning (50%), STD clinic (36%), and HIV clinic (34%).
Sixty percent of senior administrators from Ryan White-supported CHCs indicated that both they and their health centers were aware of CDC's 2006 revised recommendations, compared with 27% of administrators from non-Ryan White-supported CHCs. Among all CHCs, 53% of administrators reported having implemented routine HIV testing at their health centers; however, among medical directors/providers, only 33% reported having implemented routine HIV testing in their practices (p0.05).
Perceived barriers to implementing routine HIV testing
As shown in Table 2 , the 10 most frequently reported barriers to implementing routine HIV testing among all respondents were (1) constraints on providers' time (68%), (2) time required to administer counseling (65%), (3) time required to administer informed consent (52%), (4) lack of funding to support implementation (35%), (5) need for additional training (34%), (6) staff availability (33%), (7) informed consent statutes/ regulations (27%), (8) lack of provider buy-in (25%), (9) educating health-care providers about statutory/ regulatory requirements (25%), and (10) counseling statutes/regulations (23%). Two significantly different barriers among administrators compared with medical directors/providers were lack of provider buy-in (42% vs. 20%, p0.05) and the need to educate health-care providers about statutory/regulatory requirements (39% vs. 21%, p0.05). Among Ryan White-supported health centers compared with non-Ryan White-supported health centers, two significantly different barriers were a lack of funding to support implementation (24% vs. 45%, p0.05) and informed consent statutes/ regulations (39% vs. 16%, p0.01).
Bivariate associations of provider characteristics, perceived barriers to routine HIV testing, and other CHC factors to providing routine HIV testing
As shown in Table 3 , variables significantly associated with providing routine HIV testing according to CDC guidelines included:
1. The type of respondent was differentially associated with routine HIV testing, such that administrators were more likely than medical providers to report that their health center conducted 
Backward elimination logistic regression predicting routine HIV testing
The bivariate and multivariable predictors of routine HIV testing among the sample are presented in Table  3 . In a final multivariable model, significant unique predictors of conducting routine HIV testing included: 1. The perceived barrier of the amount of time necessary to administer informed consent was associated with decreased odds of providing routine HIV testing (adjusted OR0.21, 95% CI 0.05, 0.92).
2. The provision of on-site HIV testing by nonmedical staff resulted in increased odds of a center providing routine testing (adjusted OR9.84, 95% CI 1.77, 54.70).
DISCUSSION
Findings from this study suggest that during the two years following the release of the 2006 revised CDC recommendations, routine HIV testing was still not being implemented uniformly among Massachusetts CHCs, despite the fact that between 2005 and 2007, 31% of all individuals newly diagnosed with HIV in the state progressed to an AIDS diagnosis within two months. 38 Overall, only 38% of survey respondents identified that routine HIV testing had been implemented in their health centers; 53% of administrators reported having implemented routine HIV testing at their health centers compared with only 33% of medical directors and providers (p0.05), suggesting that few health center personnel have actually implemented routine HIV testing. Additionally, while health centers differed in the provision of HIV care and testing based on whether or not they received Ryan White funding, there were few significant differences found among CHCs regarding the implementation of routine HIV testing. For example, compared with health centers not receiving any Ryan White support, Ryan White-supported health centers served a higher annual number of HIV-infected patients (median: 169 vs. 5, p0.001) and individual patients (median: 17,500 vs. 8,000, not significant), with a higher proportion of Ryan White-supported health centers offering a dedicated HIV testing program (93% vs. 40%, p0.01). However, there were no significant Additionally, the advisory clarifies language regarding the provision of counseling and laboratory requisition forms, addressing several of the barriers identified by this study. 28 Additional strategies have sought to streamline the testing process through the use of attending nurses (rather than physicians or counselors) to initiate testing, rapid testing technologies, electronic clinical reminders to encourage providers to offer HIV testing, and provider and patient education and marketing. 18, 19, 21, 22, 39 Future efforts to increase rates of routine HIV testing among Massachusetts CHCs should consider strategies regarding time; funding; and staff education, training, and availability.
Limitations
This study was subject to several limitations. Although this study is the most comprehensive assessment of the barriers and facilitators to routine HIV testing among U.S. CHCs, it was based upon a convenience sample and did not evaluate every provider and/or health center in Massachusetts. As a cross-sectional survey, it was not possible to assess any temporal developments that may have occurred during the course of the study, such as stakeholder discussions or state-level policy changes. Given that a bill to revise the state informed consent law had been introduced but not enacted, 5 and that the Massachusetts Department of Public Health had released a June 2008 memorandum clarifying the state's opt-in policy, 40 it is unlikely that widespread policy changes had recently occurred that would be sufficient to shift provider attitudes to any significant degree. Also, as one of only nine states with laws or regulations that required separate written consent for HIV testing of nonpregnant adults at the time of this study, 5 it is important to note that generalizability of study findings to health centers in states without these requirements may be limited.
Another potential limitation to the interpretation of findings was the study definition of routine HIV testing as an opt-out procedure, 36 which would suggest that respondents affirming implementation of routine testing were in violation of Massachusetts law. However, this limitation was unlikely given that 99% of survey respondents indicated that patients were required to sign written consent for HIV testing. Rather, as this study demonstrates, there is a need for improved education and training regarding the CDC recommendations.
CONCLUSIONS
As the U.S. HIV epidemic continues unabated, novel approaches to prevention and treatment are urgently needed. The 2006 CDC revisions to longstanding testing guidelines seek to increase the number of people aware of their HIV status through the normalization of testing as a routine clinical procedure. CHCs play a crucial role in the delivery of primary care to many of society's most vulnerable populations, including low-income individuals, people in racial/ethnic and sexual minority groups, immigrants, and those seeking mental health and substance abuse treatment services. Because these populations continue to be disproportionately affected by HIV/AIDS, it is appropriate that researchers and policy makers examine conditions and devise strategies to increase rates of HIV testing in these settings.
Given this study's findings that routine HIV testing is not being implemented consistently among Massachusetts CHCs, future efforts to increase implementation should consider addressing concerns regarding time, by streamlining ways to obtain informed consent and provide counseling, improving provider buy-in, and increasing staff availability. Development of revised testing protocols addressing these concerns and tailored to the expressed needs of individual health centers is warranted.
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